Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
2,311,269
-
Share change
-
-517,273
-
Total reported value
-
$7,626,000
-
Price per share
-
$3.30
-
Number of holders
-
11
-
Value change
-
-$1,056,762
-
Number of buys
-
3
-
Number of sells
-
9
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) as of Q1 2019
As of 31 Mar 2019,
ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,311,269 shares.
The largest 10 holders included
683 Capital Management, LLC, TYNDALL CAPITAL PARTNERS L P, Point72 Asset Management, L.P., Kepos Capital LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.